The last time we touched upon Viaderma Inc (OTCMKTS:VDRM) was earlier this spring, when the stock had shot up over 800% after it received provisional patent numbers for FDA-registered Viabecline and Cannabis Technologies.

This week, we wanted to circle back around to VDRM after the company reported positive results from Phase I testing on those technologies, as well as the commencement of Phase II testing.

Viaderma Inc (OTCMKTS: VDRM) aims at developing an approved method for delivering medical and recreational cannabinoids to the body. The testing was performed in British Columbia, Canada with THC and has proven very successful.

The Company plans to conduct medical research and clinical trials to develop Cannabinoids-based pharmaceuticals and treatments for conditions including, but not limited to, psoriasis, fibromyalgia, PTSD, Depression, Anxiety and migraines. The Company will also be pursuing the “Recreational Market” in Canada with expansion plans into the USA once the proper legal standards are addressed.

“THC, CBD, and CDN are more commonly known Cannabinoids found in the Cannabis and Hemp plants but there are over 100 known Cannabinoids that our technology can be used for. As pharmaceutical companies develop different cannabinoids for treating various medical conditions our delivery system, we believe, will be the premiere way of dosing and delivering the medication transdermally,” said CEO Dr. Chris Otiko.

ViaDerma will be begin developing unique delivery systems for the effective delivery and dosage of recreational and medical cannabinoids and plans to start a grass roots product for both THC and non-THC Cannabinoids, both in a patch form, roll on and spray. The plans include distribution in every dispensary across Canada to start with, and add a website for global distribution.

The Company’s success of its first round of testing is compelling and the company plans to start continued Clinical Trials to ensure that the delivery system meets medical standards. The idea is to continue and expand testing to include pure Cannabinoid isolates, including pure THC oil, to ensure that developed products will be accepted by the medical community to treat illness as well as providing the recreational market with a more favorable alternative to smoking or ingesting.

Otiko said, “We are very excited our initial tests absorbed THC into the body using our proprietary patent pending delivery system for Cannabinoids by applying the medication onto the skin in an ointment based topical solution. Plans are, in addition to our own products, eventually license the technology to global Pharmaceutical Licensed Producers of Cannabinoids

for their medical and recreational products as well as smaller companies that produce the Home-Grown Hand Crafted Strains of medical and recreational products.”

Earlier this year the Company signed a Licensing Agreement with a Canadian group with expertise in logistics and development that includes distribution for the new and anticipated products. The Management Company is developing the trial protocols, products, and eventually the sales for the new patent pending products to countries that have accepted “Medical Marijuana” and “Recreational Use” of cannabis products and technologies for the delivery of Cannabinoids. The management company will also target countries that allow the “Clinical Studies” for medical testing such as the United Kingdom and other Asian countries. (Source: Marketwired)

We like VDRM’s approach to the recreational market in Canada, which is certainly further along in the march toward full legalization than its American counterpart. While the US is dealing with an administration that has all but reversed that momentum, Canada plans to move ahead with nationwide legalization in 2018. It’s one more aspect that draws us to continue to keep an eye on VDRM.

Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in VDRM stock, short or long.

$VDRM Viabecline DRUG News LOAD UP BEFORE THIS IS PRESS RELEASED BY THE CO

Viabecline is registered with the FDA as first aid to help prevent skin infection in minor cuts, scrapes, and burns.

Evolution is how bacteria develop resistance to the effects of all antibiotics. Papers and articles on antibiotic resistance evolution of bacteria have concentrated almost entirely on CHEMICAL threats to the bacteria. The mechanism of action of all known antibiotics is chemical in nature. Chemical (biochemical) processes previously have been the primary focus when combating bacteria drug resistance. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat. This is why Viabecline is able to kill all bacteria it has been tested on, and is also the reason why antibiotic resistance will be very difficult.

The patent-pending transdermal delivery system allows the active ingredient (tetracycline) to be carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than other antibiotics. Most other antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our product usually produce desirable results in 24 hours (or less).

Viabecline contains Vitamin D3 in the form of cholecalciferol. This is an essential component of skin healing. More benefits of Vitamin D3 can be found in the product benefits section. Viabecline not only helps prevention or treat infection, it also helps heal the skin from damage caused by the infection.

Viabecline contains Vitamin C in the form of ascorbic acid. This is an essential component of skin healing. More benefits of Vitamin D3 can be found in the product benefits section. Viabecline not only helps prevention or treat infection, it also helps heal the skin from damage caused by the infection because it contains Vitamin C and D3.

At Accuria, we like to refer to Viabecline as a “super-drug”. We believe it is one of the world’s strongest topical antibiotics. Viabecline kills all harmful Gram positive and Gram negative bacteria that have been available for testing We have put this amazing antibiotic in the hands of people without the need of a prescription needed. We use both a physical and a chemical mechanism of kill to fight pathogens.

All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of Viabecline’s strength.

Viabecline contains Vitamin D which has the following benefits for the skin:

Minimize acne, boost elasticity, stimulate collagen production, enhance radiance, lessen lines and the appearance of dark spots. Vitamin D Cream or supplements can be effective for treatment of psoriasis. Vitamin D also repairs skin damage prevents infections that might be caused due to skin injuries and rejuvenate the skin. One of the most well-known uses for Vitamin D in terms of skin is its treatment of psoriasis. Psoriasis symptoms include itchy and flaky skin, which can heal by the topical application of Vitamin D cream or by having prescribed Vitamin D supplements.

Vitamin D also helps to treat eczema and is a potential saviour of rosacea sufferers. Enzymes in the skin of rosacea sufferers can cause them to produce antimicrobial peptides in an abnormal form

Viabecline also contains Vitamin C (ascorbic acid). The antioxidant properties of vitamin C and its role in collagen synthesis make vitamin C a vital molecule for skin health. Topical ascorbic acid has the following beneficial effects on skin cells.

Production of Collagen: Vitamin C is a required component for the production of hydroxyproline and hydroxylysine, both of which are needed to bind the molecules that produce collagen. This, in turn, firms and tones the skin. Collagen deficiency makes the skin dull and lifeless. Collagen rejuvenates the skin from the roots and reduces wrinkles and symptoms of aging.

Protects Against Skin Discoloration: Vitamin C protects DNA from photochemical reactions that can lead to tumor, skin discoloration and several kinds of skin cancer. It also inhibits the production of Pyrimidine dimers that are the primary cause of melanomas in humans.

It lightens dark discoloration like skin freckles and age spots and helps to get a younger and smoother skin.

Improves Skin Texture: Collagen also provides the structure for the blood vessels. The tiny blood vessels under the skin carry oxygen and nutrients that keep the skin healthy. Without enough nutrients, the skin will become rough and dry. Creams containing Vitamin C improve the appearance and texture of the skin.

Vitamin C increases the formation of elastin which thickens, protects and heals the skin cells. The thickening effect helps retain moisture, increases the skin circulation and plumps up the skin surface.

BENEFITS

Infection Protection. It works by killing sensitive bacteria on the skin or in wounds. So far it has killed 99% of all bacteria it has been tested on. Prevention of wound infection following minor surgical or cosmetic procedures. Relieves symptoms associated with secondarily infected eczematous dermatitis. Relieves symptoms associated with secondarily infected acne. Relieves symptoms associated secondarily infected psoriasis. Soothes Painful Cuts, Scrapes, and Burns. Rapid Absorption.

POSSIBLE REACTIONS/COUNTER INDICATORS

Anyone allergic to tetracycline should not use. Do not use if allergic to any ingredient listed on this label.

Warnings For external use use only.

May be harmful is swallowed.

Do not use in eyes.

Do not use longer than 1 week unless directed by doctor.

Ask a doctor before use if you have deep or puncture wounds animal bites serious trauma. Stop use and ask a doctor if condition persists or gets worse.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison control Center right away.

PACKAGING SIZES:5 ml bottle15 ml bottle28 ml spray bottle

OTHER INFORMATION:Keep product refrigerated to preserve its effectiveness and color, stop use if product is misused. This product is an OTC antibiotic for human use. Contains no alcohol, no animal ingredients. Blended for typical skin color. May stain cloth

No claims regarding stem cell healing are implied for this product.

Found an abstract from last year on Dave Pozek of Accuria on linkedin.

First aid to help prevent skin infection in minor cuts, scrapes, and burns.

Warnings

For esternam use only. May be harmful is swallowed.

Allergy alert: Do not use if allergic to any ingredient listed on this label.

Do not use

In eyesover large areas of the bodylonger than 1 week unless directed by doctor

Ask a doctor before use if you have

?deep or puncture woundsanimal bitesserious trauma

Stop use and ask a doctor if condition persists or gets worse.

Keep our of reach of children. If swallowed, get medical help or contact a Poison control Center right away.

DirectionsClean the affected areaApply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily.May be covered with a sterile bandage.

Other InformationKeep product refrigerated to preserve its effectiveness and colorStop use if product is misusedThis product is an OTC antibiotic for human useContains no alcohol, no animal ingredientsBlended for typical skin colorMay stain clothNo claims regarding stem cell healing are implied for this product.